NVNO

SEC source: 0001493152-26-042629 · ownership.xml · nonDerivative · entry 1

Duhay Francis · CIK 0001760582 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,351

F1 · kind: This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025.

SEC source: 0001493152-26-028426 · ownership.xml · nonDerivative · entry 1

Duhay Francis · CIK 0001760582 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,362

F1 · kind: This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025.

SEC source: 0001493152-26-010047 · ownership.xml · nonDerivative · entry 1

Duhay Francis · CIK 0001760582 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,502

F1 · kind: This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025.

F2 · price: This transaction was executed in multiple trades during the day at prices ranging from $11.5200 to $11.5450, inclusive. The weighted-average price is reported above. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were completed.

SEC source: 0001493152-25-028394 · ownership.xml · derivative · entry 1

Alavi Hamed · CIK 0001964081 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires 2031-11-30

F1 · derivative.exercise_date: The restricted stock units were issued to the Reporting Person on November 30, 2021 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan and the Restricted Stock Unit Agreement, subject to vesting upon the achievement of specified performance milestones. The applicable milestones were not achieved, and accordingly, the Reporting Person has agreed to voluntarily surrender and cancel the unvested Restricted Stock Units.

SEC source: 0001493152-25-028392 · ownership.xml · derivative · entry 2

Glickman Marc H. · CIK 0001730171 · SVP & Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100,000 shares

Expires 2031-11-30

F1 · derivative.exercise_date: The restricted stock units were issued to the Reporting Person on November 30, 2021 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan and the Restricted Stock Unit Agreement, subject to vesting upon the achievement of specified performance milestones. The applicable milestones were not achieved, and accordingly, the Reporting Person has agreed to voluntarily surrender and cancel the unvested Restricted Stock Units.

SEC source: 0001493152-25-028396 · ownership.xml · derivative · entry 2

BERMAN ROBERT ANDREW · CIK 0001258360 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 200,000 shares

Expires 2031-11-30

F1 · derivative.exercise_date: The restricted stock units were issued to the Reporting Person on November 30, 2021 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan and the Restricted Stock Unit Agreement, subject to vesting upon the achievement of specified performance milestones. The applicable milestones were not achieved, and accordingly, the Reporting Person has agreed to voluntarily surrender and cancel the unvested Restricted Stock Units.

SEC source: 0001493152-25-027510 · ownership.xml · nonDerivative · entry 1

Duhay Francis · CIK 0001760582 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,544

F1 · kind: This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025.

F2 · price: This transaction was executed in multiple trades during the day at prices ranging from $0.3554 to $0.3573, inclusive. The weighted-average price is reported above. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were completed.

SEC source: 0001493152-25-027832 · ownership.xml · derivative · entry 1

Jenusaitis Matthew · CIK 0001357864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,883

Underlying: Common Stock · 135,883 shares

Expires 2035-12-11

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 11, 2025 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2026 calendar year.

SEC source: 0001493152-25-027848 · ownership.xml · derivative · entry 1

Duhay Francis · CIK 0001760582 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,883

Underlying: Common Stock · 135,883 shares

Expires 2035-12-11

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 11, 2025 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2026 calendar year.

SEC source: 0001493152-25-027834 · ownership.xml · derivative · entry 1

Gray Robert · CIK 0001788480 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,883

Underlying: Common Stock · 135,883 shares

Expires 2035-12-11

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 11, 2025 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended . The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2026 calendar year.

SEC source: 0001493152-25-027826 · ownership.xml · derivative · entry 1

Shrivastava Sanjay · CIK 0001754588 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,883

Underlying: Common Stock · 135,883 shares

Expires 2035-12-11

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 11, 2025 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended . The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2026 calendar year.

SEC source: 0001493152-25-013837 · ownership.xml · nonDerivative · entry 1

Duhay Francis · CIK 0001760582 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 97,444

F1 · kind: This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025.

F2 · price: This transaction was executed in multiple trades during the day at prices ranging from $0.8205 to $0.84, inclusive. The weighted-average price is reported above. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were completed.

SEC source: 0001641172-25-011744 · ownership.xml · derivative · entry 1

Bright Jennifer · CIK 0001937848 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Stock · 350,000 shares

Expires 2035-05-19

F1 · security: The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended.

F2 · derivative.exercise_date: The stock options shall vest quarterly, over a three (3) year period, with a one (1) year cliff, subject to the reporting person's continued service with the Company.

SEC source: 0001493152-25-000058 · ownership.xml · nonDerivative · entry 1

Gray Robert · CIK 0001788480 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,155

SEC source: 0001493152-25-000160 · ownership.xml · nonDerivative · entry 1

Duhay Francis · CIK 0001760582 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,344

SEC source: 0001493152-24-052112 · ownership.xml · nonDerivative · entry 1

Shrivastava Sanjay · CIK 0001754588 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,288

SEC source: 0001493152-24-050865 · ownership.xml · nonDerivative · entry 1

BERMAN ROBERT ANDREW · CIK 0001258360 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 222,236

SEC source: 0001493152-24-051172 · ownership.xml · nonDerivative · entry 1

Jenusaitis Matthew · CIK 0001357864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,545

SEC source: 0001493152-24-051143 · ownership.xml · derivative · entry 1

Alavi Hamed · CIK 0001964081 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2034-12-18

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2027.

SEC source: 0001493152-24-051144 · ownership.xml · derivative · entry 1

Glickman Marc H. · CIK 0001730171 · SVP & Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2034-12-18

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2027.

SEC source: 0001493152-24-051146 · ownership.xml · derivative · entry 1

BERMAN ROBERT ANDREW · CIK 0001258360 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2034-12-18

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2027.

SEC source: 0001493152-24-051145 · ownership.xml · derivative · entry 1

Jenusaitis Matthew · CIK 0001357864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,752

Underlying: Common Stock · 19,752 shares

Expires 2034-12-18

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2025 calendar year.

SEC source: 0001493152-24-051142 · ownership.xml · derivative · entry 1

Duhay Francis · CIK 0001760582 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,752

Underlying: Common Stock · 19,752 shares

Expires 2034-12-18

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2025 calendar year.

SEC source: 0001493152-24-051147 · ownership.xml · derivative · entry 1

Gray Robert · CIK 0001788480 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,752

Underlying: Common Stock · 19,752 shares

Expires 2034-12-18

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2025 calendar year.

SEC source: 0001493152-24-051148 · ownership.xml · derivative · entry 1

Shrivastava Sanjay · CIK 0001754588 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,752

Underlying: Common Stock · 19,752 shares

Expires 2034-12-18

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2025 calendar year.

SEC source: 0001493152-24-010168 · ownership.xml · derivative · entry 3

Alavi Hamed · CIK 0001964081 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,666

Underlying: Common Stock · 8,334 shares

Expires 2033-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Amended and Restated 2016 Omnibus Incentive Plan. The award is subject to time-based vesting and will vest in equal quarterly installments during the three calendar years through 2026. The portion of the stock options exercised in this transaction was fully vested and exercisable on the transaction date.

SEC source: 0001493152-24-010168 · ownership.xml · nonDerivative · entry 2

Alavi Hamed · CIK 0001964081 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

SEC source: 0001493152-24-010168 · ownership.xml · nonDerivative · entry 1

Alavi Hamed · CIK 0001964081 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,334

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001493152-23-044054 · ownership.xml · derivative · entry 1

Alavi Hamed · CIK 0001964081 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2033-12-05

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2026.

SEC source: 0001493152-23-044062 · ownership.xml · derivative · entry 1

Glynn Craig · CIK 0001809590 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2033-12-05

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2026.

SEC source: 0001493152-23-044057 · ownership.xml · derivative · entry 1

Glickman Marc H. · CIK 0001730171 · SVP & Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2033-12-05

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2026.

SEC source: 0001493152-23-044055 · ownership.xml · derivative · entry 1

BERMAN ROBERT ANDREW · CIK 0001258360 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2033-12-05

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2026.

SEC source: 0001493152-23-044059 · ownership.xml · derivative · entry 1

Jenusaitis Matthew · CIK 0001357864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,856

Underlying: Common Stock · 13,856 shares

Expires 2033-12-05

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2024 calendar year.

SEC source: 0001493152-23-044058 · ownership.xml · derivative · entry 1

Gray Robert · CIK 0001788480 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,856

Underlying: Common Stock · 13,856 shares

Expires 2033-12-05

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2024 calendar year.

SEC source: 0001493152-23-044060 · ownership.xml · derivative · entry 1

Shrivastava Sanjay · CIK 0001754588 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,856

Underlying: Common Stock · 13,856 shares

Expires 2033-12-05

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2024 calendar year.

SEC source: 0001493152-23-044056 · ownership.xml · derivative · entry 1

Duhay Francis · CIK 0001760582 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,856

Underlying: Common Stock · 13,856 shares

Expires 2033-12-05

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2024 calendar year.

SEC source: 0001493152-22-034312 · ownership.xml · derivative · entry 1

Jenusaitis Matthew · CIK 0001357864 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,403

Underlying: Common Stock · 8,403 shares

Expires 2032-11-30

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on November 30, 2022 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2023 calendar year.

SEC source: 0001493152-22-034307 · ownership.xml · derivative · entry 1

Shrivastava Sanjay · CIK 0001754588 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,403

Underlying: Common Stock · 8,403 shares

Expires 2032-11-30

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on November 30, 2022 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2023 calendar year.

SEC source: 0001493152-22-034315 · ownership.xml · derivative · entry 1

Gray Robert · CIK 0001788480 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,403

Underlying: Common Stock · 8,403 shares

Expires 2032-11-30

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on November 30, 2022 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2023 calendar year.

SEC source: 0001493152-22-034316 · ownership.xml · derivative · entry 1

Duhay Francis · CIK 0001760582 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,403

Underlying: Common Stock · 8,403 shares

Expires 2032-11-30

F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on November 30, 2022 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2023 calendar year.

SEC source: 0001493152-22-026070 · ownership.xml · derivative · entry 2

Jenusaitis Matthew · CIK 0001357864 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,041 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") converts into one share of common stock of enVVeno Medical Corporation.

F2 · derivative.exercise_date: On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of the RSUs occurred in September 2020, 2021 and 2022.

F2 · derivative.expiration_date: On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of the RSUs occurred in September 2020, 2021 and 2022.

SEC source: 0001493152-22-026070 · ownership.xml · nonDerivative · entry 1

Jenusaitis Matthew · CIK 0001357864 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,925

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") converts into one share of common stock of enVVeno Medical Corporation.

SEC source: 0001493152-22-026071 · ownership.xml · derivative · entry 2

Gray Robert · CIK 0001788480 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,041 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") converts into one share of common stock of enVVeno Medical Corporation.

F2 · derivative.exercise_date: On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of the RSUs occurred in September 2020, 2021 and 2022.

F2 · derivative.expiration_date: On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of the RSUs occurred in September 2020, 2021 and 2022.

SEC source: 0001493152-22-026071 · ownership.xml · nonDerivative · entry 1

Gray Robert · CIK 0001788480 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,655

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") converts into one share of common stock of enVVeno Medical Corporation.

SEC source: 0001493152-22-023461 · ownership.xml · nonDerivative · entry 1

Duhay Francis · CIK 0001760582 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,911

SEC source: 0001493152-22-018361 · ownership.xml · nonDerivative · entry 1

Shrivastava Sanjay · CIK 0001754588 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,888

SEC source: 0001493152-22-017957 · ownership.xml · nonDerivative · entry 1

BERMAN ROBERT ANDREW · CIK 0001258360 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,236

SEC source: 0001493152-21-030331 · ownership.xml · derivative · entry 2

Glynn Craig · CIK 0001809590 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,925

Underlying: Common Stock · 125,925 shares

Expires 2031-11-30

F2 · derivative.exercise_date: The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2024.

SEC source: 0001493152-21-030331 · ownership.xml · nonDerivative · entry 1

Glynn Craig · CIK 0001809590 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

F1 · price: The Reporting Person was granted 50,000 restricted stock units on November 30, 2021 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The restricted stock units are subject to milestone-based vesting as follows: (i) 50% upon SAVVE (Surgical Anti-reflux Venous Valve Endoprosthesis) endpoints being achieved, and (ii) 50% upon the Pre-Market Approval of the VenoValve.

SEC source: 0001493152-21-030333 · ownership.xml · derivative · entry 2

Glickman Marc H. · CIK 0001730171 · SVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,700

Underlying: Common Stock · 265,700 shares

Expires 2031-11-30

F2 · derivative.exercise_date: The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2024.